6 results on '"Clarke, Michael"'
Search Results
2. Recent advances in cancer stem cells
- Author
-
Cho, Robert W and Clarke, Michael F
- Subjects
- *
CANCER cells , *STEM cells , *CELL differentiation , *TUMORS , *LEUKEMIA , *MICE - Abstract
The theory of cancer stem cells states that a subset of cancer cells within a tumor has the ability to self-renew and differentiate. Only those cells within a tumor that have these two properties are called cancer stem cells. This concept was first demonstrated in the study of leukemia where only cells with specific surface antigen profiles were able to cause leukemia when engrafted into immunodeficient mice. In recent years solid tumors were studied utilizing similar techniques in mice. Human tumors where evidence of cancer stem cells has been published include tumors of the breast, brain, pancreas, head and neck, and colon. If this difference in tumorigenicity of cancer cells also occurs in patients, then the ability to enrich for cancer stem cells lays an important groundwork for future studies where mechanisms involved in cancer stem cells can now be investigated. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
3. Self-renewal and solid tumor stem cells.
- Author
-
Al-Hajj, Muhammad and Clarke, Michael F.
- Subjects
- *
STEM cells , *TUMORS , *CANCER cells , *BREAST cancer , *CENTRAL nervous system , *ONCOGENES - Abstract
Solid tumors arise in organs that contain stem cell populations. The tumors in these tissues consist of heterogeneous populations of cancer cells that differ markedly in their ability to proliferate and form new tumors. In both breast cancers and central nervous system tumors, cancer cells differ in their ability to form tumors. While the majority of the cancer cells have a limited ability to divide, a population of cancer stem cells that has the exclusive ability to extensively proliferate and form new tumors can be identified based on marker expression. Growing evidence suggests that pathways that regulate the self-renewal of normal stem cells are deregulated in cancer stem cells resulting in the continuous expansion of self-renewing cancer cells and tumor formation. This suggests that agents that target the defective self-renewal pathways in cancer cells might lead to improved outcomes in the treatment of these diseases.Oncogene (2004) 23, 7274-7282. doi:10.1038/sj.onc.1207947 [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
4. Cancer Stem Cells: Models and Concepts.
- Author
-
Dalerba, Piero, Cho, Robert W., and Clarke, Michael F.
- Subjects
- *
STEM cells , *CANCER cells , *TUMORS , *ANTIBODY diversity , *GENETIC mutation , *PATHOLOGY - Abstract
Although monoclonal in origin, most tumors appear to contain a heterogeneous population of cancer cells. This observation is traditionally explained by postulating variations in tumor microenviromnent and coexistence of multiple genetic subclones, created by progressive and divergent accumulation of independent somatic mutations. An additional explanation, however, envisages human tumors not as mere monoclonal expansions of transformed cells, but rather as complex tridimensional tissues where cancer cells become functionally heterogeneous as a result of differentiation. According to this second scenario, tumors act as caricatures of their corresponding normal tissues and are sustained in their growth by a pathological counterpart of normal adult stem cells, cancer stem cells. This model, first developed in human myeloid leukemias, is today being extended to solid tumors, such as breast and brain cancer. We review the biological basis and the therapeutic implications of the stem cell model of cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
5. The Biology of Cancer Stem Cells.
- Author
-
Lobo, Neethan A., Shimono, Yohei, Dalong Qian, and Clarke, Michael F.
- Subjects
- *
CANCER , *CANCER cells , *TUMORS , *METASTASIS , *STEM cells , *CELL differentiation , *CARCINOGENESIS , *ONTOGENY - Abstract
Cancers originally develop from normal cells that gain the ability to proliferate aberrantly and eventually turn malignant. These cancerous cells then grow clonally into tumors and eventually have the potential to metastasize. A central question in cancer biology is, which cells can be transformed to form tumors? Recent studies elucidated the presence of cancer stem cells that have the exclusive ability to regenerate tumors. These cancer stem cells share many characteristics with normal stem cells, including self-renewal and differentiation. With the growing evidence that cancer stem cells exist in a wide array of tumors, it is becoming increasingly important to understand the molecular mechanisms that regulate self-renewal and differentiation because corruption of genes involved in these pathways likely participates in tumor growth. This new paradigm of oncogenesis has been validated in a growing list of tumors. Studies of normal and cancer stem cells from the same tissue have shed light on the ontogeny of tumors. That signaling pathways such as Broil and Wnt have similar effects in normal and cancer stem cell self renewal suggests that common molecular pathways regulate both populations. Understanding the biology of cancer stem cells will contribute to the identification of molecular targets important for future therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
6. Therapeutic implications of cancer stem cells
- Author
-
Al-Hajj, Muhammad, Becker, Michael W, Wicha, Max, Weissman, Irving, and Clarke, Michael F
- Subjects
- *
CANCER , *CELLS , *TUMORS , *STEM cells , *CANCER cells , *THERAPEUTICS - Abstract
Most cancers comprise a heterogenous population of cells with marked differences in their proliferative potential as well as the ability to reconstitute the tumor upon transplantation. Cancer stem cells are a minor population of tumor cells that possess the stem cell property of self-renewal. In addition, dysregulation of stem cell self-renewal is a likely requirement for the development of cancer. This new model for cancer will have significant ramifications for the way we study and treat cancer. In addition, through targeting the cancer stem cell and its dysregulated self-renewal, our therapies for treating cancer are likely to improve. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.